205 related articles for article (PubMed ID: 23558689)
21. 18F-FDG PET-CT for detecting recurrent gastric adenocarcinoma: results from a Non-Oriental Asian population.
Sharma P; Singh H; Suman SK; Sharma A; Reddy RM; Thulkar S; Bal C; Malhotra A; Kumar R
Nucl Med Commun; 2012 Sep; 33(9):960-6. PubMed ID: 22692579
[TBL] [Abstract][Full Text] [Related]
22. Is methylene diphosphonate bone scan necessary for initial staging of Ewing sarcoma if 18F-FDG PET/CT is performed?
Ulaner GA; Magnan H; Healey JH; Weber WA; Meyers PA
AJR Am J Roentgenol; 2014 Apr; 202(4):859-67. PubMed ID: 24660717
[TBL] [Abstract][Full Text] [Related]
23. The role of 18F-FDG PET/CT in the metabolic characterization of lung nodules in pediatric patients with bone sarcoma.
Cistaro A; Lopci E; Gastaldo L; Fania P; Brach Del Prever A; Fagioli F
Pediatr Blood Cancer; 2012 Dec; 59(7):1206-10. PubMed ID: 22745027
[TBL] [Abstract][Full Text] [Related]
24. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
26. (18) F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
Al-Ibraheem A; Buck AK; Benz MR; Rudert M; Beer AJ; Mansour A; Pomykala KL; Haller B; Juenger H; Scheidhauer K; Schwaiger M; Herrmann K
Cancer; 2013 Mar; 119(6):1227-34. PubMed ID: 23233156
[TBL] [Abstract][Full Text] [Related]
27. Can FDG-PET/CT replace blind bone marrow biopsy of the posterior iliac crest in Ewing sarcoma?
Kasalak Ö; Glaudemans AWJM; Overbosch J; Jutte PC; Kwee TC
Skeletal Radiol; 2018 Mar; 47(3):363-367. PubMed ID: 29124298
[TBL] [Abstract][Full Text] [Related]
28. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels.
Sanli Y; Kuyumcu S; Ozkan ZG; Kilic L; Balik E; Turkmen C; Has D; Isik G; Asoglu O; Kapran Y; Adalet I
Ann Nucl Med; 2012 Aug; 26(7):551-8. PubMed ID: 22644560
[TBL] [Abstract][Full Text] [Related]
29. F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study.
Johnsen B; Boye K; Rosendahl K; Biermann M; Trovik C; Aukland SM
Clin Physiol Funct Imaging; 2016 Nov; 36(6):441-446. PubMed ID: 26039107
[TBL] [Abstract][Full Text] [Related]
30. Askin tumor: CT and FDG-PET/CT imaging findings and follow-up.
Xia T; Guan Y; Chen Y; Li J
Medicine (Baltimore); 2014 Jul; 93(6):e42. PubMed ID: 25058144
[TBL] [Abstract][Full Text] [Related]
31. The diagnostic accuracy of
Lemans JVC; Hobbelink MGG; IJpma FFA; Plate JDJ; van den Kieboom J; Bosch P; Leenen LPH; Kruyt MC; Glaudemans AWJM; Govaert GAM
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):999-1008. PubMed ID: 30523391
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Value of SUVmax Measured by Pretreatment Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients with Ewing Sarcoma.
Hwang JP; Lim I; Kong CB; Jeon DG; Byun BH; Kim BI; Choi CW; Lim SM
PLoS One; 2016; 11(4):e0153281. PubMed ID: 27100297
[TBL] [Abstract][Full Text] [Related]
33. The role of
Angelini A; Ceci F; Castellucci P; Graziani T; Polverari G; Trovarelli G; Palmerini E; Ferrari S; Fanti S; Ruggieri P
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1712-1720. PubMed ID: 28405727
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic value of
Kassem TW; Abdelaziz O; Emad-Eldin S
Diagn Interv Imaging; 2017 Oct; 98(10):693-698. PubMed ID: 28734778
[TBL] [Abstract][Full Text] [Related]
35. 18F-Fluoride PET/CT for detection of bone metastasis in patients with renal cell carcinoma: a pilot study.
Sharma P; Karunanithi S; Chakraborty PS; Kumar R; Seth A; Julka PK; Bal C; Kumar R
Nucl Med Commun; 2014 Dec; 35(12):1247-53. PubMed ID: 25171438
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
Hahn S; Hecktor J; Grabellus F; Hartung V; Pöppel T; Kimmig R; Forsting M; Antoch G; Heusner TA
Acta Radiol; 2012 Jun; 53(5):518-23. PubMed ID: 22547387
[TBL] [Abstract][Full Text] [Related]
37. Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
Shin DS; Shon OJ; Byun SJ; Choi JH; Chun KA; Cho IH
Skeletal Radiol; 2008 May; 37(5):415-21. PubMed ID: 18309481
[TBL] [Abstract][Full Text] [Related]
38. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of virtual 18F-FDG PET/CT bronchoscopy for the detection of lymph node metastases in non-small cell lung cancer patients.
Herbrik M; Treffert J; Geiger B; Riegger C; Hartung V; Rosenbaum-Krumme SJ; Forsting M; Antoch G; Heusner TA
J Nucl Med; 2011 Oct; 52(10):1520-5. PubMed ID: 21908390
[TBL] [Abstract][Full Text] [Related]
40. Role of
Albano D; Zizioli V; Treglia G; Odicino F; Giubbini R; Bertagna F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):10-16. PubMed ID: 30396849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
